In order to investigate the safety of rapidly infused intravenous valproate in children with seizures, the drug was administered to 18 patients (age range, 1-16 years) at doses ranging from 7.5 to 41.5 mg/kg and rates of 1.5 to 11 mg/kg per minute. Forty-eight intravenous valproate doses were administered during 19 hospital admissions (range, 1-16 doses per admission). Only one adverse event was reported; a 9-year-old male experienced burning at the infusion site while receiving 660 mg intravenous valproate at 6 mg/kg per minute. The patient tolerated three subsequent infusions (one of 330 mg and two of 165 mg) at the same rate with no further discomfort. Electrocardiogram results, available for 18 admissions, revealed no arrhythmias, bradycardias, or hypotensive episodes. No abnormal laboratory results were reported. Rapid intravenous valproate infusion appears to be safe in pediatric patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pediatrneurol.2006.11.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The potential ameliorative effect of mesenchymal stem cells-derived exosomes on cerebellar histopathology and their modifying role on PI3k-mTOR signaling in rat model of autism spectrum disorder.
J Mol Histol
January 2025
Department of Histology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Article Synopsis
- Autism spectrum disorder (ASD) is a serious neurodevelopmental issue, and this study investigates the effects of administering MSCs-derived exosomes after birth on a rat model of ASD.
- The research involved dividing male rat pups into control, VPA (exposed to a neurotoxin), and VPA treated with exosomes, assessing changes in behavior and cerebellar structure.
- Results showed that VPA groups exhibited increased activity, social impairments, and disrupted cerebellar structure, while those treated with exosomes showed improvements in histological integrity and behaviors, supported by changes in specific signaling pathways.
Strategies to innovate emergency care of status epilepticus.
Neurotherapeutics
December 2024
Department of Neurology and Neuroscience Brain Institute University of Virginia, School of Medicine, Health Sciences Center, Box 801330, Charlottesville, VA 22908-1330, USA. Electronic address:
Generalized Convulsive status epilepticus (SE) is a neurological emergency because prolonged convulsions can cause respiratory compromise and neuronal injury. Compromised GABA-mediated inhibition is a defining feature of SE, and many current therapies are benzodiazepines, which are allosteric modulators of GABA-A receptors. Many patients with medically refractory epilepsy are at risk for SE.
View Article and Find Full Text PDFEffectiveness and Safety of Pharmacologic Therapies for Migraine in the Emergency Department: A Systematic Review and Bayesian Network Meta-analysis.
Ann Emerg Med
December 2024
Department of Emergency Medicine, Stony Brook University, Stony Brook, NY.
Study Objective: We performed a systematic review and Bayesian network meta-analysis to determine which pharmacologic therapies are relatively more effective and safer for migraine in adult patients who present to the emergency department (ED).
Methods: We searched MEDLINE, Embase, and Web of Science from inception to February 9, 2024. Eligible studies were randomized controlled trials that enrolled adult participants presenting to ED with migraine and compared one pharmacologic therapy to another or placebo.
PBPK modelling for the evaluation of drug-drug interaction between meropenem and valproic acid.
Br J Clin Pharmacol
November 2024
Department of Pharmacy, Minhang Hospital, Fudan University, Shanghai, China.
Article Synopsis
- - The study investigated the drug-drug interaction (DDI) between meropenem (MEPM) and valproic acid (VPA) using a physiologically based pharmacokinetic (PBPK) model to understand how they affect each other in the body.
- - Results showed that combining MEPM with VPA decreased the plasma concentration of VPA significantly, indicating that the presence of MEPM affects how VPA is processed in the body, particularly through changes in absorption and elimination rates.
- - The researchers concluded that multiple factors contribute to the DDI and recommended spacing doses of MEPM and VPA by 4-6 hours or using intravenous VPA when both medications are needed together in clinical practice.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!